Short interest in Drugs Made In America Acquisition Corp (NASDAQ:DMAA) increased during the last reporting period, rising from 24.04K to 24.24K. This put 0.08% of the company's publicly available shares short.

Short interest in Drugs Made In America Acq Corp (XNAS:DMAA) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.

Based on the recent average volume of 27.80K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.